{
  "image_filename": "figure_p10_det_9_000.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/figure_p10_det_9_000.png",
  "image_type": "Figure",
  "page_number": 10,
  "block_id": "det_9_000",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A flowchart outlining pediatric influenza vaccination recommendations for the 2022\u201323 season: it asks if the child received \u22652 doses of trivalent or quadrivalent influenza vaccine before July 1, 2022 and then directs to either 1 dose or 2 doses (\u22654 weeks apart) of the 2022\u201323 vaccine. does not support the claim because the figure only presents dosing guidelines and contains no information on vaccine production methods, mutations, or vaccine effectiveness",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A flowchart outlining pediatric influenza vaccination recommendations for the 2022\u201323 season: it asks if the child received \u22652 doses of trivalent or quadrivalent influenza vaccine before July 1, 2022 and then directs to either 1 dose or 2 doses (\u22654 weeks apart) of the 2022\u201323 vaccine.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the figure only presents dosing guidelines and contains no information on vaccine production methods, mutations, or vaccine effectiveness",
    "confidence_notes": null
  }
}